what determines the value of crypto Top Top stories

Australia's 3-year bond yields fell by 3 basis points after the RBA commented on inflation.Huang Wentao of China CITIC Construction Investment Co., Ltd. and others: It is estimated that deficit ratio will rise to over 4% in 2025, and it is expected that the stock and debt will continue. On December 9th, the Political Bureau of the Central Committee held a meeting to analyze and study the economic work in 2025. Huang Wentao, chief economist of CITIC Jiantou, and Liu Tianyu, macro analyst of CITIC Jiantou, believe that the policy tone of this Politburo meeting is quite proactive, which shows that the central government has made a full assessment and policy reserve for the pressures and risks that may be encountered in economic development next year, which has strongly echoed the expectations of economic entities. Huang Wentao and Liu Tianyu pointed out that GDP growth in the fourth quarter is expected to reach more than 5.2%, achieving the expected goal of annual economic growth of around 5%. On this basis, the annual growth target of about 5% will also be the basic premise of policy discussion in the next few years. Since the fourth quarter of this year, the fiscal policy has been continuously overweight. This time, the fiscal policy is set to be "more active", which indicates that the fiscal policy will expand again. It is estimated that deficit ratio will increase to over 4% in 2025. Both stocks and debts are expected to continue. Unconventional countercyclical adjustment policies not only provide sufficient impetus for the recovery of economic vitality, but also provide strong support for improving expectations and reviving confidence, and provide sufficient source of living water for the capital market. The stock market is expected to continue to strengthen and the risk-free rate of return is expected to continue to decline.Israel once again launched an attack on Damascus and its surrounding areas in Syria. On the 10th local time, it was learned from the Syrian media that Israel once again launched an attack on Damascus, the capital of Syria, and its surrounding areas. At present, the Israeli side has no response to this. (CCTV)

The investment of Shanghai private equity venture capital industry in the first three quarters was 45.947 billion yuan, a year-on-year decrease of 50%. On December 10th, at the 17th Bund Finance Shanghai International Equity Investment Forum, the development report of Shanghai private equity venture capital industry in 2024 was officially released. According to the report, in the first three quarters of 2024, there were 327 investments in Shanghai private equity venture capital industry, a year-on-year decrease of 47%; The total investment was 45.947 billion yuan, a year-on-year decrease of 50%. All rounds of financing activities have decreased, especially the A+ round, B round, D round and private placement round. The report also shows that in the first three quarters of 2024, the total amount of investment subscribed by Shanghai LP was about 67 billion yuan, a year-on-year increase of 15.61%; A total of 301 LPs were invested, a year-on-year decrease of 50.25%.At the close of early trading, the main contracts of domestic futures rose more and fell less. Coke and BR rubber rose by more than 3%, while rebar, glass, hot coil, iron ore and Shanghai Bank rose by more than 2%. In terms of decline, the European line of container transportation fell by nearly 3%, while asphalt, alumina and No.20 glue fell by more than 1%.Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.

Dotinolole, a new drug used by Weicai to treat gout, was approved for marketing in China. On December 10th, Weicai China announced that its new urate reuptake inhibitor Dotinolole tablets (trade name: Youlesi) had been approved by National Medical Products Administration (NMPA) in China, and its indication was gout with hyperuricemia.Li Jun, the former first-level senior police sergeant of the Economic Crime Investigation Corps of Jiangxi Provincial Public Security Department, was examined and investigated. On December 10th, WeChat official account WeChat reported that Li Jun, the former first-level senior police sergeant of the Economic Crime Investigation Corps of Jiangxi Provincial Public Security Department, was suspected of serious violation of discipline and law, and took the initiative to explain the problem to the organization. At present, he is being examined by the Discipline Inspection and Supervision Team of Jiangxi Provincial Commission for Discipline Inspection in the Provincial Public Security Department and supervised by the Supervision Committee of Yushan County, Shangrao City.Reserve Bank of Australia President Brock: The policy needs to be carefully considered. Recent data are mixed and somewhat weak.